The effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome

Deputy for Research of Shiraz University of Medical Sciences0 个研究点目标入组 180 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•(1) having regular menstrual cycles (3–8 days of menstruation between intervals of 22–35 days); (2) not taking medications such as hormonal contraceptives, antipsychotics, or vitamins; (3) not having contraindications to taking dydrogesterone or supplements containing calcium or vitamin D; (4) meeting the American College of Obstetrics and Gynecology and American Psychiatric Association standard diagnostic criteria for PMS (5 or more symptoms present for most of the time during the 7–10 days prior to menstruation; symptoms beginning to remit a few days after the onset of the follicular phase and absent in the week following the menses; and at least 1 symptom in the psychotic domain); (5) diagnostic criteria confirmed by prospective daily symptom ratings during at least 2 consecutive cycles; (6) symptoms markedly interfering with work or school activities and relationships; (7) symptoms not merely an exacerbation of another condition such as epilepsy or a major depressive disorder, panic disorder, or personality disorder; and (8) not using daily foods containing a great deal of calcium and/or vitamin D.

发起方

Deputy for Research of Shiraz University of Medical Sciences